Anacor Pharmaceuticals, Inc. Announces Retirement of Zhi Hong from Board of Directors

Anacor Pharmaceuticals (NASDAQ:ANAC) announced today that Zhi Hong, Ph.D., has retired from its Board of Directors effective May 25, 2011. Dr. Hong has been a member of the Anacor Board of Directors since 2009. Dr. Hong is the Senior Vice President and Head of the Infectious Disease Center of Excellence for Drug Discovery at GlaxoSmithKline (GSK).
MORE ON THIS TOPIC